Interval cytoreductive surgical outcome following administration of standard versus dose-dense neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer. - Mueller, J.J.; Kelly, A.; Zhou, Q.; Iasonos, A.; Long Roche, K.; Sonoda, Y.; O'Cearbhaill, R.; Chi, D.S.; Zivanovic, O.; Gardner, G.J. (Gynecologic Oncology, 2016)